ValuEngine reduces Surgery Partners to ‘sell’ — 3 quick notes

ValuEngine lowered its rating on Surgery Partners’ shares from a “hold” to a “sell,” according to The Ledger Gazette.

Advertisement

Here are three quick notes:

1. Surgery Partners’ shares opened Nov. 24 trading at $8.60 per share.

2. The company’s P/E ratio totals 57.

3. Surgery Partners’ debt-to-equity ratio is 1.56.

More articles on transactions/valuations:
Illinois hospital completes $9.4M outpatient surgery center expansion — 3 insights
Doheny Eye Institute purchases new $50M facility — 5 key notes
Surgery Partners loses up to $9M in Q3 revenue from Hurricanes Harvey, Irma & more: 4 ASC company notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.